Lv1
70 积分 2022-09-19 加入
U.S. FDA Approved Drugs from 2015–June 2020: A Perspective
24天前
已完结
Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy
1个月前
已完结
Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery
1个月前
已完结
Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma
1个月前
已完结
A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas
1个月前
已完结
Membrane-Decorated Exosomes for Combination Drug Delivery and Improved Glioma Therapy
1个月前
已完结
Nanomedicine Remodels Tumor Microenvironment for Solid Tumor Immunotherapy
1个月前
已完结
The implications of IDH mutations for cancer development and therapy
1个月前
已完结
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
2个月前
已完结
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas
2个月前
已完结
皖公网安备34019202002308
